Laurus Labs Limited — Financials & Forensics
Sector: Healthcare · NSE: LAURUSLABS · BSE: 540222 · ISIN: INE947Q01028
01 Oct 2026
Add LAURUSLABS to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹4,936 Cr | ₹6,041 Cr | ₹5,041 Cr | ₹5,554 Cr | ₹6,813 Cr |
| EBITDA | ₹1,422 Cr | ₹1,592 Cr | ₹778 Cr | ₹1,055 Cr | ₹1,778 Cr |
| EBITDA margin | 28.8% | 26.4% | 15.4% | 19.0% | 26.1% |
| Profit after tax | ₹828 Cr | ₹790 Cr | ₹161 Cr | ₹358 Cr | ₹889 Cr |
Deeper analysis
Recent filings by Laurus Labs Limited
-
Trading Window
25 Sep 2026 · Regulatory Compliance
-
Please see attached enclosure.
18 Sep 2026 · Financial Results
-
Analysts/Institutional Investor Meet/Con. Call Updates
15 Sep 2026 · General Update
-
Please see annexed enclosure.
10 Sep 2026 · General Update
-
Please see annexed enclosure.
31 Aug 2026 · General Update
Never miss a filing again
About Laurus Labs Limited on Indian Stock Alerts
Indian Stock Alerts tracks Laurus Labs Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.